We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
109 hedge funds and large institutions have $846M invested in Lexicon Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
7% more funds holding
Funds holding: 102 → 109 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 35
24% less capital invested
Capital invested by funds: $1.12B → $846M (-$274M)
Holders
109
Holders Change
+7
Holders Change %
+6.86%
% of All Funds
3.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
30
Reduced
35
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$8.52M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.15M |
| 3 |
JG
Jefferies Group
New York
|
+$4.8M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.22M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$2.55M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.23M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.16M |
